Laxai

LAXAI is a leading drug discovery, development, and manufacturing partner that operates as a Contract Research Organization (CRO). They provide integrated services across the drug discovery and development spectrum, focusing on delivering rapid and innovative solutions to the pharmaceutical industry. With an extensive range of offerings, LAXAI is dedicated to ensuring the successful progression of pharmaceutical projects from concept to market.

Services include:

- Accelerated Stability Studies
- Analytical Services
- Bioanalytical Services
- Bioavailability Studies
- Biometrics
- Chemistry (CMC)
- Medicinal
- Chiral Separations
- R&D
- Chromatography
- Clinical Supply Management
- Clinical Trials Management
- Clinical Trials
- Manufacturing
- Consulting
- Regulatory
- Contract Research (CRO)
- Custom Synthesis
- Data Management
- Dissolution Testing
- Distillation
- Distribution
- Documentation Support Services
- IND/NDA Submissions
- Software & Technology
- 21CFR11 / Annex 11
- LIMS
- Process Automation
- IVR (Interactive Voice Response)
- Library Synthesis
- Bioequivalence
- Clinical Trial Materials
- Mass Spectrometry
- Process Development
- Micro FT-IR Analysis
- Nonclinical Research
- Organic Synthesis
- Packaging
- Patient Recruitment
- Pharmacokinetics
- Pilot-Scale Filling
- Process R&D
- Process Validation Studies
- R&D Services
- Scale-Up
- Stability Studies
- Stability
- ICH
- UV-VIS Spectrophotometer Analysis
- Validation
- Clinical
- Wet Chemical Analysis
- APIs (Active Pharmaceutical Ingredients)
- Regulatory Services

LAXAI continues to be a vital partner in the pharmaceutical landscape, providing comprehensive solutions for drug development and manufacturing needs. For further details, please visit laxai.com.